Latest Multiple Myeloma Research Foundation Stories
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma.
The John Theurer Cancer Center at Hackensack University Medical Center, a top 50 U.S. News best hospital for cancer, is one of the first four clinical sites enrolling patients in a landmark study designed to uncover the molecular segments and variations of multiple myeloma.
SOUTH SAN FRANCISCO, Calif. and NORWALK, Conn., Aug. 3, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) and the Multiple Myeloma Research Foundation (MMRF) today announced the initiation of an expanded access program for carfilzomib, a selective, next-generation proteasome inhibitor.
S. 3988/A. 6233 will ensure that health plans already providing insurance coverage for chemotherapy will provide equal coverage for both IV/injected and oral therapies.
Hardy Jones, ocean conservationist, myeloma patient and International Myeloma Foundation (IMF) member, has written a powerful book, The Voice of The Dolphins, highlighting the devastating impact of pollutants on dolphins and our world's oceans....
The IMF Advocacy team with IMF Volunteer Advocates, made up of patients and caregivers, went to Washington to meet with legislators and staff on May 25th for the One Voice Against Cancer (OVAC) Lobby Day.